SCHEMBL3833284

SCHEMBL3833284

CC(=O)C[C@H](C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10175142 1.00
SCHEMBL599696 1.00
SCHEMBL27360126 0.97 ALDH1A1 (0.52)
Iodomethane SCHEMBL8981617 0.95 ALDH1A1 (0.50)
SCHEMBL30213431 0.88 ALDH1A1 (0.44)
Levulinic Acid SCHEMBL30924217 0.86 LMNA (0.61)
SCHEMBL2343475 0.79 ALDH1A1 (0.46)
SCHEMBL27571000 0.79 KDM4E (0.44)
SCHEMBL791253 0.79
SCHEMBL2599566 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-20180134665-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-05-17 US disclosed
US-20170348324-A1 DERIVATIVES OF BETULIN GLAXOSMITHKLINE LLC (US) 2017-12-07 US disclosed
US-20170252356-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING HIV WITH DERIVATIVES OF BETULIN GLAXOSMITHKLINE LLC 2017-09-07 US disclosed
US-20170022242-A1 NOVEL ANTIVIRAL AND ANTITUMORAL COMPOUNDS Katholieke Universiteit Leuven, KU LEUVEN R&D (BE) 2017-01-26 US disclosed
US-9340513-B2 Propenoate derivatives of betulin GLAXOSMITHKLINE LLC (US) 2016-05-17 US disclosed
US-20160120878-A1 DERIVATIVES OF BETULIN GLAXOSMITHKLINE LLC 2016-05-05 US disclosed
US-9102685-B2 Derivatives of betulin GLAXOSMITHKLINE LLC (US) 2015-08-11 US disclosed
US-20150218142-A1 Derivatives of Betulin GLAXOSMITHKLINE LLC (US) 2015-08-06 US disclosed
US-20140357643-A1 Derivatives of Betulin GLAXOSMITHKLINE LLC 2014-12-04 US disclosed
US-20060199822-A1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE & CO. (US) 2006-09-07 US disclosed
US-7091219-B2 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors G. D. SEARLE & CO. (US) 2006-08-15 US disclosed
EP-1586558-A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors G.D. Searle LLC. (US) 2005-10-19 EP disclosed
US-20040063771-A1 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors G.D. SEARLE & CO. (US) 2004-04-01 US disclosed
US-6569882-B2 Viricides; enzyme inhibitors G. D. SEARLE & CO. 2003-05-27 US disclosed
US-20030013751-A1 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors G.D. SEARLE & CO. (US) 2003-01-16 US disclosed
US-6384036-B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors G.D. SEARLE & CO. 2002-05-07 US disclosed
US-6143747-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 2000-11-07 US disclosed
EP-0804428-A1 BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE &amp; CO. (US) 1997-11-05 EP disclosed
WO-1996022287-A1 BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-07-25 WO disclosed